Filing metadata

Accession number
0001209191-22-052187
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Oct 04, 2022
Reporting period
Apr 21, 2022
Description
Insider transaction

Explore SEC Filings Hub